Next Article in Journal
A New Look for the Red Macroalga Palmaria palmata: A Seafood with Polar Lipids Rich in EPA and with Antioxidant Properties
Previous Article in Journal
Antioxidant Peptides from the Protein Hydrolysate of Spanish Mackerel (Scomberomorous niphonius) Muscle by in Vitro Gastrointestinal Digestion and Their In Vitro Activities
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 17
Issue 9
10.3390/md17090532
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Anti-Obesity Effect of Polysaccharide-Rich Red Algae (Gelidium amansii) Hot-Water Extracts in High-Fat Diet-Induced Obese Hamsters

by
Tsung-Han Yang
1,
Chen-Yuan Chiu
2,
Ting-Jang Lu
3,
Shing-Hwa Liu
4,5,6,* and
Meng-Tsan Chiang
1,*
1
Department of Food Science, National Taiwan Ocean University, Keelung 20224, Taiwan
2
Medical and Pharmaceutical Industry Technology and Development Center, New Taipei City 24886, Taiwan
3
Institute of Food Science and Technology, National Taiwan University, Taipei 10617, Taiwan
4
Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan
5
Department of Pediatrics, College of Medicine, National Taiwan University Hospital, Taipei 10051, Taiwan
6
Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2019, 17(9), 532; https://doi.org/10.3390/md17090532
Submission received: 21 August 2019 / Revised: 12 September 2019 / Accepted: 12 September 2019 / Published: 13 September 2019
Browse Figures
Review Reports Versions Notes

Abstract

:
This study investigated the anti-obesity effect of a polysaccharide-rich red algae Gelidium amansii hot-water extract (GHE) in high-fat (HF) diet-induced obese hamsters. GHE contained 68.54% water-soluble indigestible carbohydrate polymers. Hamsters were fed with a HF diet for 5 weeks to induce obesity, and then randomly divided into: HF group, HF with 3% guar gum diet group, HF with 3% GHE diet group, and HF with orlistat (200 mg/kg diet) group for 9 weeks. The increased weights of body, liver, and adipose in the HF group were significantly reversed by GHE supplementation. Lower plasma leptin, tumor necrosis factor-α, and interleukin-6 levels were observed in the GHE+HF group compared to the HF group. GHE also increased the lipolysis rate and decreased the lipoprotein lipase activity in adipose tissues. GHE induced an increase in the phosphorylation of AMP-activated protein kinase (AMPK) and the protein expressions of peroxisome proliferator-activated receptor alpha (PPARα) and uncoupling protein (UCP)-2 in the livers. The decreased triglyceride and total cholesterol in the plasma and liver were also observed in obese hamsters fed a diet with GHE. These results suggest that GHE exerts a down-regulation effect on hepatic lipid metabolism through AMPK phosphorylation and up-regulation of PPARα and UCP-2 in HF-induced obese hamsters.

Graphical Abstract

1. Introduction

Obesity is a global health care issue that is associated with metabolic diseases such as type 2 diabetes and hyperlipidemia [1,2]. Obesity, especially increased visceral adipose tissue, is a major risk factor for cardiovascular disease [3]. Hypertrophic adipocytes increase the generation of inflammatory cytokines such as tumor necrosis factor-α (TNFα) and interleukin-6 (IL-6), which may cause chronic inflammation and increase the risk of developing cardiovascular disease [4]. Functional foods have been demonstrated to possess anti-obesity potential [5,6]. Therefore, functional foods or food ingredients against obesity may come to be recognized as a promising therapeutic strategy for prediabetes and metabolic diseases.
Gelidium amansii (GA) is edible red algae, which is widely distributed in Japan, Korea, China, and northeast Taiwan. The agar product (1,3-linked b-D-galactopyranose and 1,4-linked 3,6-anhydro-a-L-galactopyranose units) of GA [7] can be prepared to form a gel [8]. It has been shown that GA possesses hypoglycemic effects in diabetic rats [9] and diabetic patients [10]. A recent study showed that the hot-water extracts of GA (GHE), an agar-filtered product, can reduce plasma and liver lipids by decreasing cholesterol absorption and increasing bile acid and fecal fat excretion in an animal model [11]. The water soluble fibers in GA and GHE may contribute to reducing lipid accumulation in the liver and adipose tissues. On the other hand, ethanol extracts of GA have been found to inhibit lipid accumulation in a 3T3-L1 cell model [12], and decrease the weights of body and epididymal fat and the levels of serum total cholesterol (TC) and triglyceride (TG) in an obese mouse model [13]. These findings suggest that GHE possesses beneficial effects for the improvement of lipid metabolism. However, the detailed effect and mechanism of GHE on obesity still remain to be clarified.
Hamsters make a suitable animal model for studying lipid metabolism, because their cholesterol and bile acid metabolism resemble to that of humans [14,15]. High fat (HF) diets have been shown to promote obesity and hyperlipidemia [16,17]. In addition, guar gum (GG), which is rich in water-soluble fibers processed from the endosperm of the cluster bean, is known for its hypolipidemic and anti-obesity effects [18,19]. In the present study, we used hamsters fed with a HF diet as an obese animal model to investigate the comparative effects of GHE and GG on lipid metabolism and obesity, and evaluated its possible mechanism of action. Orlistat, which is known as a potent inhibitor of gastric and pancreatic lipase and acts to reduce dietary fat absorption [20], was used as a positive control.

2. Results

2.1. Analysis of Carbohydrate Content and Monosaccharide Composition

The hot-water extract preparation was a polysaccharide-rich fraction of GA and contained 68.54 ± 1.43% carbohydrate polymers. Galactose (86.0%) was the major monosaccharide of the water-soluble indigestible polysaccharide from GHE, with low amounts of fucose (8.3%), mannose (1.5%), xylose (1.1%), and acidic sugar, glucuronic acid (2.0%). Rhamnose and glucose were also only detected in a much lower amounts (<1%) (Table 1).

2.2. Effects of GHE on Body and Tissue Weights in HF Diet-Fed Hamsters

Supplementation of GHE, GG, or orlistat significantly decreased body weight in HF diet-fed hamsters (Figure 1 and Table 2). As shown in Figure 1, hamsters fed a HF diet for 9 weeks had significantly increased liver and adipose weights, which could be significantly reversed by GHE, GG, or orlistat supplementation. GHE supplementation had lower adipose tissue weights than those fed a diet with GG supplementation in HF diet-fed hamsters. In addition, orlistat, but not both GHE and GG, significantly increased the food intake in hamsters fed with a HF diet (Table 2).

2.3. Effects of GHE on Plasma, Liver, and Fecal Lipids and Adipocytokines in HF Diet-Fed Hamsters

Hamsters fed with a HF diet had a significant increase in the plasma TC and TG levels, which could be significantly reversed by GHE, GG, or orlistat supplementation (Table 3). Moreover, animals fed the HF diet significantly enhanced TC and TG contents in the liver, which could also be significantly reversed by GHE, GG, or orlistat supplementation (Table 4). GHE supplementation had lower hepatic triglyceride contents than those fed a diet with GG supplementation in HF diet-fed hamsters (Table 4). Both GHE and orlistat supplementation significantly increased the fecal TC and TG contents; GG supplementation significantly increased the fecal TG, but not TC, contents (Table 4).
As shown in Table 3, hamsters fed with the HF diet had a significant increase in plasma leptin, IL-6, and TNF-α levels, which could be significantly reversed by GHE, GG, or orlistat supplementation.

2.4. Effects of GHE on TG Contents and Lipolysis Rate and LPL Activity in Adipose Tissues and Lipid Metabolism-Related Protein Expressions in the Livers

Hamsters fed the HF diet significantly increased TG contents in the adipose tissue, which could be significantly reversed by GHE, GG, or orlistat supplementation (Figure 2). It is interesting to note that the GHE group had lower TG contents in the adipose tissue than those of the GG group.
Hamsters fed the HF diet showed a decreased lipolysis rate and increased LPL activity in the adipose tissues (Figure 3). Supplementation of GHE, GG, or orlistat in the diet significantly increased the lipolysis rate and decreased the accumulation of TG and LPL activity in the adipose tissues. Higher lipolysis rate was observed in animals treated with GHE as compared to the GG group (Figure 3A).
The protein expressions of phosphorylated adenosine monophosphate (AMP)-activated protein kinase (AMPK), peroxisome proliferator activated receptor (PPAR)-α, and uncoupling protein (UCP)-2 were significantly decreased in the livers of obese hamsters, which could be significantly reversed by GHE, GG, or orlistat supplementation (Figure 4).

3. Discussion

In this study, we demonstrate for the first time that supplementation of GHE in HF diet-induced obese hamsters effectively induces (1) a reduction in body and adipose tissue weights, (2) a decrease in plasma TC/TG levels and hepatic TC/TG accumulation and adipose TG content, (3) an increase in fecal TC/TG content, (4) adipose tissue lipolysis and fatty acid β-oxidation, and (5) AMPK-related signals.
Our previous study showed that hamsters fed a HF diet with 1.5% GHE for 6 weeks effectively activate the phosphorylation of AMPK and reduce the protein expressions of SREBP-1 and SREBP-2 in the livers, thereby decreasing the hepatic lipogenesis and lipid accumulation as compared with HF diet-fed alone group [11]. In the present study, hamsters were fed with a HF diet for 5 weeks to induce obesity. GHE (3%) supplementation for 9 weeks significantly induced an anti-obesity effect and an increase in the AMPK phosphorylation and PPAR-α and UCP-2 protein expression in obese hamsters. AMPK activation is known as a major therapeutic target for obesity [21], fatty liver [22], and hyperlipidemia [23]. Yoon et al. showed that an increase in the expression of phosphorylated AMPK protein led to an increase in the expression of PPARα protein and an increase in the oxidation of fatty acids [24]. PPARα regulates target genes associated with fatty acid oxidation and lipid metabolism such as UCP-2 [25]. Therefore, one of the mechanisms by which obese hamsters with guar gum and GHE treatment can reduce the lipid contents in the liver may be due to promoting the oxidation of fatty acids in the liver by increasing the activities of phosphorylated AMPK, PPARα, and UCP-2 in the liver.
Consumption of a high-fat diet leads to obesity and hyperlipidemia in hamsters. Obese hamsters fed guar gum, GHE, or orlistat significantly reduced body weight, adipose tissue weight, and plasma levels of TC and TG. Orlistat has been reported to be an inhibitor of small intestinal lipase that reduces dietary fat absorption, and is used to treat obesity [20]. GG is rich in water-soluble fiber, and ingestion of GG can decrease plasma and liver lipids by increasing bile acid excretion to decrease fat absorption [26,27,28]. Frias and Sgarbieri showed that GG contained approximately 75% water-soluble fiber [29]. The GG and GHE used in the present study contained approximately 82.5% and 68.6% water-soluble fiber, respectively [11]. Thus, one of the reasons that GG and GHE can improve plasma and liver lipid metabolism may be related to the high levels of water-soluble fiber.
Adipose tissue is known to be an important endocrine organ that generates adipocytokines to affect energy metabolism and insulin sensitivity [30]. Hypertrophic adipocytes produce large amounts of inflammatory factors such as leptin, TNF-α, and IL-6 [31]. Feeding a red algae (GA) diet has been shown to significantly decrease plasma TNF-α, leptin, and TC/TG levels, but not affect the weights of body, liver, and adipose tissue, in a high fructose diet-impaired glucose tolerance rat model [32]. In the present study, both GHE (hot-water extract of red algae) and GG could significantly decrease plasma leptin, TNF-α, IL-6, and TC/TG levels and the weights of body, liver, and adipose tissue in obese hamsters. These results indicate that both GHE and GG may regulate plasma adipocytokines by lowering adipose tissue weight in hamsters. However, GHE is more effective than GG in reducing adipose tissue weight and the TG contents in the liver and adipose tissue. Moreover, lipoprotein lipase (LPL) activity in adipose tissue has been suggested to be closely related to obesity formation [33]. The present study also found that both GHE and GG could enhance the phosphorylation of AMPK in the liver, increase the lipolysis rate, and decrease the accumulation of TG and the LPL activity in the adipose tissues of obese hamsters. Watt et al. have demonstrated that increased AMPK phosphorylation can promote hormone-sensitive lipase (HSL) activation in the adipose tissue [34]. GG has been shown to enhance the activation of AMPK in both the liver and adipose tissue of HF diet-fed mice [35]. Kang et al. also found that the feeding of a red algae ethanol extract could increase the AMPK phosphorylation in the liver of obese mice and increase the amount of HSL protein in the adipose tissue [36]. Therefore, our findings suggest that GHE supplementation may decrease LPL activity and increase the rate of lipolysis, which lowers triglyceride content in the adipose tissue thus reducing the adipose tissue weight.
In this study, we found that galactose (86.0%) was the major monosaccharide of the water-soluble indigestible polysaccharide from GHE. We propose that galactans, indigestible polysaccharides, is a major and potent component of the seaweed extract. A similar polysaccharide rich extract from Ceylon moss (Gelidium amansii) has been reported by Wi et al. (2009) [37]. The report indicated that the seaweed contains 53.4% carbohydrates, consisting of galactose (23.4%) and glucose (22.3%). The difference of monosaccharide composition with low glucose content is a result of digestion treatment of α-amylase and amyloglucosidase used in our protocols. Our results provide more information by using a sophisticated hydrolysis protocol to release glycosidic linkages with less degradation. The structural details of the galactans need to be elucidated in future studies.

4. Materials and Methods

4.1. Reagents and Solvents

Barium acetate, chloroform, heparin, hydrochloric acid (HCl), isoproterenol, methanol, N-tris-(hydroxymethyl)methyl-2-aminoethanesulfonic acid, phenol, p-nitrophenyl butyrate, sodium acetate, sodium hydroxide (NaOH), sulfuric acid, and trifluoroacetic acid (TFA) were obtained from Sigma-Aldrich (St. Louis, MO, USA). A cholesterol enzymatic kit (Audit Diagnostics, Cork, Ireland), a TG enzymatic kit (Audit Diagnostics, Cork, Ireland), a glucose detection kit (Audit Diagnostics, Cork, Ireland), and plasma TNF-α, IL-6, and leptin ELISA kits (Assay Design, Ann Arbor, MI, USA) were used. A radio immunoprecipitation buffer (Cell Signaling Technology, Beverly, MA, USA) and an enhanced chemiluminescence kit (PerkinElmer, Waltham, MA, USA) were used.

4.2. Hot-Water Extract of GA (GHE)

The dry material of GA was obtained from the market at Keelung, Taiwan. GA was stored at 4 °C until used. For preparing GHE, GA (20 g) was added to the deionized water (400 mL), and then autoclaved at 121 °C for 20 min. After cooling, the samples were filtered and lyophilized. The harvest weight of GHE was 5.71 g, which the recovery rate was about 28.5%. The general composition of GHE, determined by the method of the Association of Official Agricultural Chemists (AOAC) [38], involved moisture 6.5%, ash 4.6%, crude fat 0.25%, and crude protein 6.7%. Moreover, GHE contained 68.6% water-soluble dietary fiber, according to the analysis by the Food Industry Research and Development Institute, Hsinchu, Taiwan [38].

4.3. Analysis of Carbohydrate Content and Monosaccharide Composition

GHE was re-dissolved in the deionized water and digested by α-amylase at pH 6.0, 30 min, 95 °C; protease at pH 7.5, 30 min, 60 °C; and amyloglucosidase at pH 4.5, 30 min, 60 °C. After the enzymes digestion, polysaccharides were precipitated and collected with 4 volumes of 95% ethanol.
The carbohydrate content was determined as previously described [39]. D-galactose was used as the standard and dissolved in the deionized water to construct the standard curve. The sample (200 μL) and 5% (W/V) phenol solution (200 μL) were mixed. After the solution was mixed, 1 mL 18 M sulfuric acid was added into the solution. After the solution was mixed and cooled, the absorbance at 490 nm using a spectrophotometer (Helios Omega, Thermo Fisher Scientific, San Jose, CA, USA) was measured. The absorbance value was subjected to the standard curve and the total carbohydrate concentration of the solution was calculated.
The monosaccharide composition analysis was performed as previously described [40]. The polysaccharides samples were methanolyzed with anhydrous 2 M HCl in absolute methanol, in a hydrolytic tube at 70 °C for 12 h. After methanolysis, the methanolysis reagent in the resulting solution was evaporated, and the residue was then subjected to acid hydrolysis with 2 M TFA at 100 °C for 1.5 h. In the resulting solution, TFA was removed by washing with methanol until TFA was removed. The sugars in the hydrolyzate were analyzed by high performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD). In neutral monosaccharide analysis, the analyte was separated by CarboPac PA10 guard column (4 mm × 50 mm) coupled with CarboPac PA10 IC Columns (4 mm × 250 mm). Columns were eluted at a flow rate of 0.5 mL/min with 25 mM NaOH, containing 1 mM barium acetate. In acid monosaccharide analysis, the analyte was separated by CarboPac PA10 guard column (4 mm × 50 mm) coupled with CarboPac PA10 IC Columns (4 mm × 250 mm). Columns were eluted at a flow rate of 0.8 mL/min with 75 mM NaOH, containing 1 mM barium acetate and 150 mM sodium acetate.

4.4. Animals and Treatments

The adult male Syrian hamsters (6-week-old) were obtained from The National Laboratory Animal Center (Taipei, Taiwan). Hamsters were individually housed in stainless steel cages in a room (23 ± 1 °C and 40–60% relative humidity) with a 12-h light–dark cycle. Hamsters were acclimated for 1 week and fed a standard laboratory diet (5001 rodent diet, Lab Diet, PMI Nutrition International Inc., Brentwood, MO, USA). Hamsters were then divided into normal and obese groups. Hamsters of the obese group were fed with a high-fat (HF) diet for 5 weeks to induce obesity. The obese hamsters were then randomly divided into four experimental groups: HF group, HF with 3% GG diet group (GG group), HF with 3% GHE diet group (GHE group), and HF with orlistat (200 mg/kg diet) group (OL group). The experimental diet compositions are listed in Table 5. Each experimental group was fed the experimental diets for 9 weeks. The normal control group was fed a standard laboratory diet (5001 rodent diet). Animals were given ad libitum access to food and water. Body weight was detected every week and fecal samples were collected during the final 3 days in week 9. The fecal samples were dried and weighed. This animal study was approved by the Animal House Management Committee of the National Taiwan Ocean University. All animal experiments were performed in accordance with the guidelines for the care and use of laboratory animals, as issued by the National Laboratory Animal Center. GG powder (GGP 200 LI-MV) was obtained from Lotus International (Rajasthan, India). Orlistat was as a positive control that was obtained from Weidar Chemical & Pharmaceutical CO., LTD. (Taichung, Taiwan).

4.5. Collection of Blood and Tissue Samples

At the end of the experiment, overnight-fasted hamsters were sacrificed under CO2 anesthesia. Blood was collected and plasma was prepared by centrifugation at 1750× g for 20 min (4 °C). Liver and perirenal and para-epididymal adipose tissues were isolated and weighed. All tissue samples were immediately frozen and stored at ‒80 °C until further analysis.

4.6. Determination of Plasma Lipids

Both TC and TG levels in the plasma were determined by using a cholesterol enzymatic kit (Audit Diagnostics) and TG enzymatic kit (Audit Diagnostics), respectively.

4.7. Determination of Plasma Glucose, Tumor Necrosis Factor α (TNF-α), Interleukin 6 (IL-6), and Leptin

Plasma glucose was measured using a glucose detection kit (Audit Diagnostics, Cork, Ireland). The plasma levels of TNF-α, IL-6, and leptin were determined by the ELISA kits (Assay Design, Ann Arbor, MI, USA).

4.8. Determination of Liver Lipids, Fecal Lipids, and Bile Acid Levels

Both liver and fecal lipids were extracted with a chloroform/methanol solution (v/v, 2:1) as previously described by Folch et al. [41]. The levels of both TG and TC were determined by the method of Carlson and Goldfarb [42]. Fecal bile acids were extracted and detected according to the method of Cheng and Lai [43].

4.9. Lipolysis Rate Measurement

Lipolysis rate measurement was determined as previously described [44]. The 0.2 g of adipose samples were minced and placed into 2 mL of N-tris-(hydroxymethyl)methyl-2-aminoethanesulfonic acid (25 mM) buffer containing isoproterenol (1 μM), and then incubated at 37 °C. After 1, 2, and 3 h of incubation, 0.2 mL of medium was used to analyze the concentrations of glycerol using a commercial reagent (RANDOX GY105, Amtrim, UK), and then the absorbance at 520 nm was recorded by a Hitachi U2800A spectrophotometer. The lipolysis rate was indicated by micromoles of glycerol released per gram of tissue per hour.

4.10. Lipoprotein Lipase (LPL) Activity

LPL activity in adipose samples was determined as previously described [45]. The 0.1 g of adipose samples were minced and placed into Krebs-Ringer bicarbonate buffer (pH 7.4) containing heparin (10 units/mL) for 60 min at 37 °C. The heparin solution was mixed with an equal volume of p-nitrophenyl butyrate (pNPB; 2 mM). Absorbance at 400 nm was recorded by a Hitachi U2800A spectrophotometer. LPL activity was indicated as the amount of p-nitrophenol formed over the 10 min incubation.

4.11. Western Blot Analysis

The proteins in the livers were extracted using a radio immunoprecipitation buffer (Cell Signaling Technology). The 40 μg of tissue proteins were separated on 10% sodium dodecyl sulfate polyacrylamide gels and transferred to polyvinylidene fluoride membranes (Bio-Rad, CA, USA). After blocking, the membranes were probed with primary antibodies for β-actin (Biovision, Mountain View, CA, USA), AMPK, phospho-AMPK (Thr172) (Cell Signaling Technology), PPAR-α (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and UCP-2 (Origene, Rockville, MD, USA) overnight at 4 °C, followed by incubation with horseradish peroxidase linked secondary antibodies for 1 h at room temperature, and then detected by enhanced chemiluminescence (PerkinElmer). Signal intensities were quantitated using the Quantity One Software (BioRad, Hercules, CA, USA).

4.12. Statistical Analysis

Data are presented as mean ± standard deviation. The significant difference from the respective controls for each experimental condition was assessed by one-way analysis of variance and two-tailed Student t-test. The statistical analysis was performed by statistical software SPSS for Windows version 12.0 (SPSS, Chicago, IL, USA).

5. Conclusions

Based on these findings, supplementation of GHE to HF diet-induced obese hamsters can activate AMPK phosphorylation and up-regulate PPAR-α and UCP-2 protein expressions, which increase the fatty acid β-oxidation in the liver. GHE has beneficial effects on reducing the weight of body and adipose tissue, plasma TC and TG levels, TG content in adipose tissue, and hepatic lipid accumulation.

Author Contributions

Conceptualization, S.-H.L. and M.-T.C.; methodology, T.-J.L., T.-H.Y., and C.-Y.C.; software, T.-H.Y. and C.-Y.C.; validation, T.-J.L., S.-H.L., C.-Y.C., and T.-H.Y.; formal analysis, C.-Y.C. and T.-H.Y.; investigation, S.-H.L. and M.-T.C.; resources, S.-H.L. and M.-T.C.; data curation, T.-J.L. and T.-H.Y.; writing—original draft preparation, S.-H.L. and M.-T.C.; writing—review and editing, S.-H.L. and M.-T.C.; visualization, S.-H.L., C.-Y.C., T.-H.Y., and M.-T.C.; supervision, S.-H.L. and M.-T.C.; project administration, M.-T.C.; funding acquisition, M.-T.C.

Funding

This research was partially funded by the Ministry of Science and Technology, Taiwan (R.O.C.) (107-2320-B-019-002) and National Taiwan Ocean University (92200001).

Conflicts of Interest

The authors declare no competing financial interests.

References

  1. Aubin, M.C.; Lajoie, C.; Clément, R.; Gosselin, H.; Calderone, A.; Perrault, L.P. Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: Therapeutic potential of resveratrol. J. Pharmacol. Exp. Ther. 2008, 325, 961–968. [Google Scholar] [CrossRef] [PubMed]
  2. Crawford, A.G.; Cote, C.; Couto, J.; Daskiran, M.; Gunnarsson, C.; Haas, K.; Haas, S.; Nigam, S.C.; Schuette, R. Prevalence of obesity, type II diabetes mellitus, hyperlipidemia, and hypertension in the United States: Findings from the GE Centricity Electronic Medical Record database. Popul. Health Manag. 2010, 13, 51–61. [Google Scholar] [CrossRef] [PubMed]
  3. Peixoto, M.R.; Benício, M.H.; Latorre, M.R.; Jardim, P.C. Waist circumference and body mass index as predictors of hypertension. Arq. Bras. Cardiol. 2006, 87, 462–470. [Google Scholar] [CrossRef] [PubMed]
  4. Kaur, J. A comprehensive review on metabolic syndrome. Cardiol. Res. Pract. 2014, 2014, 943162. [Google Scholar] [CrossRef] [PubMed]
  5. Lai, C.S.; Wu, J.C.; Pan, M.H. Molecular mechanism on functional food bioactives for anti-obesity. Curr. Opin. Food Sci. 2015, 2, 9–13. [Google Scholar] [CrossRef]
  6. Bell, S.J.; Goodrick, G.K. A functional food product for management of weight. Crit. Rev. Food Sci. Nutr. 2002, 42, 163–178. [Google Scholar] [CrossRef] [PubMed]
  7. Labropoulos, K.C.; Niesz, D.E.; Danforth, S.C.; Kevrekidis, P.G. Dynamic rheology of agar gels: Theory and experiments. Part I. Development of a rheological model. Carbohydr. Polym. 2002, 50, 393–406. [Google Scholar] [CrossRef]
  8. Chen, Y.H.; Tu, C.J.; Wu, H.T. Growth-inhibitory effects of the red alga gelidium amansii on cultured cells. Biol. Pharm. Bull. 2004, 27, 180–184. [Google Scholar] [CrossRef] [PubMed]
  9. Wang, H.; Zhou, X.; Tang, F.; Zuo, S.H. An experimental study on the hypoglycemic effect of agar polysaccharide in diabetic rats. Health Med. Res. Pract. 2011, 4, 8–10. [Google Scholar]
  10. Maeda, H.; Yamamoto, R.; Hirao, K.; Tochikubo, O. Effects of agar (kanten) diet on obese patients with impaired glucose tolerance and type 2 diabetes. Diabetes Obes. Metab. 2005, 7, 40–46. [Google Scholar] [CrossRef] [PubMed]
  11. Yang, T.H.; Yao, H.T.; Chiang, M.T. Red algae (Gelidium amansii) hot water extracts ameliorate lipid metabolism in hamsters fed a high fat diet. J. Food Drug Anal. 2017, 25, 931–938. [Google Scholar] [CrossRef] [PubMed]
  12. Seo, M.J.; Lee, O.H.; Choi, H.S.; Lee, B.Y. Extract from edible red seaweed (Gelidium amansii) inhibits lipid accumulation and ros production during differentiation in 3T3-L1 cells. Prev. Nutr. Food Sci. 2012, 17, 129–135. [Google Scholar] [CrossRef] [PubMed]
  13. Kang, M.C.; Kang, N.; Kim, S.Y.; Lima, I.S.; Ko, S.C.; Kim, Y.T.; Kim, Y.B.; Jeung, H.D.; Choi, K.S.; Jeon, Y.J. Popular edible seaweed, Gelidium amansii prevents against diet-induced obesity. Food Chem. Toxicol. 2016, 90, 181–187. [Google Scholar] [CrossRef] [PubMed]
  14. Zhang, Z.; Wang, H.; Jiao, R.; Peng, C.; Wong, Y.M.; Yeung, V.S.; Huang, Y.; Chen, Z.Y. Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods. Mol. Nutr. Food Res. 2009, 53, 921–930. [Google Scholar] [CrossRef] [PubMed]
  15. Guo, F.; Huang, C.; Liao, X.; Wang, Y.; He, Y.; Feng, R.; Li, Y.; Sun, C. Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters. Mol. Nutr. Food Res. 2011, 55, 1809–1818. [Google Scholar] [CrossRef] [PubMed]
  16. Kuem, N.; Song, S.J.; Yu, R.; Yun, J.W.; Park, T. Oleuropein attenuates visceral adiposity in high-fat diet-induced obese mice through the modulation of WNT10b-and galanin-mediated signalings. Mol. Nutr. Food Res. 2014, 58, 2166–2176. [Google Scholar] [CrossRef] [PubMed]
  17. Sung, Y.Y.; Kim, D.S.; Choi, G.; Kim, S.H.; Kim, H.K. Dohaekseunggi-tang extract inhibits obesity, hyperlipidemia, and hypertension in high-fat diet-induced obese mice. BMC Complement. Altern. Med. 2014, 14, 372. [Google Scholar] [CrossRef]
  18. Landin, K.; Holm, G.; Tengborn, L.; Smith, U. Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men. Am. J. Clin. Nutr. 1992, 56, 1061–1065. [Google Scholar] [CrossRef]
  19. Krotkiewski, M. Effect of guar gum on body-weight, hunger ratings and metabolism in obese subjects. Br. J. Nutr. 1984, 52, 97–105. [Google Scholar] [CrossRef]
  20. Heck, A.M.; Yanovski, J.A.; Calis, K.A. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 2000, 20, 270–279. [Google Scholar] [CrossRef]
  21. Lee, J.W.; Choe, S.S.; Jang, H.; Kim, J.; Jeong, H.W.; Jo, H.; Tadi, S.; Park, M.G.; Kwak, T.H.; Kim, J.M.; et al. AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity. J. Lipid Res. 2012, 53, 1277–1286. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Shen, L.; Xing, Y.; Wang, D.Q.; Howles, P.; Basford, J.E.; Wang, J.; Xiong, Y.Q.; Hui, D.Y.; Woods, S.C.; Liu, M. Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats. J. Lipid Res. 2013, 54, 1430–1438. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Guo, P.; Kai, Q.; Gao, J.; Lian, Z.Q.; Wu, C.M.; Wu, C.A.; Zhu, H.B. Cordycepin prevents hyperlipidemia in hamsters fed a high-fat diet via activation of AMP-activated protein kinase. J. Pharmacol. Sci. 2010, 113, 395–403. [Google Scholar] [CrossRef] [PubMed]
  24. Yoon, M.J.; Lee, G.Y.; Chung, J.J.; Ahn, Y.H.; Hong, S.H.; Kim, J.B. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 2006, 55, 2562–2570. [Google Scholar] [CrossRef] [PubMed]
  25. Arakawa, M.; Masaki, T.; Nishimura, J.; Seike, M.; Yoshimatsu, H. The effects of branched-chain amino acid granules on the accumulation of tissue triglycerides and uncoupling proteins in diet-induced obese mice. Endocr. J. 2011, 58, 161–170. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Ide, T.; Moriuchi, H.; Nihimoto, K. Hypolipidemic effects of guar gum and its enzyme hydrolysate in rats fed highly saturated fat diets. Ann. Nutr. Metab. 1991, 35, 34–44. [Google Scholar] [CrossRef] [PubMed]
  27. Butt, M.S.; Ahmad, A.; Sharif, M.K. Influence of pectin and guar gum composite flour on plasma biochemical profile of streptozotocin-induced diabetic male albino rats. Int. J. Food Prop. 2007, 10, 345–361. [Google Scholar] [CrossRef]
  28. Jakobsdottir, G.; Xu, J.; Molin, G.; Ahrne, S.; Nyman, M. High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fiber counteracts these effects. PLoS ONE 2013, 8, e80476. [Google Scholar] [CrossRef]
  29. Frias, A.C.; Sgarbieri, V.C. Guar gum effects on food intake, blood serum lipids and glucose levels of Wistar rats. Plant Foods Hum. Nutr. 1998, 53, 15–28. [Google Scholar] [CrossRef]
  30. Pittas, A.G.; Joseph, N.A.; Greenberg, A.S. Adipocytokines and insulin resistance. J. Clin. Endocrinol. Metab. 2004, 89, 447–452. [Google Scholar] [CrossRef]
  31. Kern, P.A.; Ranganathan, S.; Li, C.; Wood, L.; Ranganathan, G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2001, 280, E745–E751. [Google Scholar] [CrossRef] [PubMed]
  32. Liu, H.C.; Chang, C.J.; Yang, T.H.; Chiang, M.T. Long-term feeding of red algae (Gelidium amansii) ameliorates glucose and lipid metabolism in a high fructose diet-impaired glucose tolerance rat model. J. Food Drug Anal. 2017, 25, 543–549. [Google Scholar] [CrossRef] [PubMed]
  33. Wang, H.; Eckel, R.H. Lipoprotein lipase: From gene to obesity. Am. J. Physiol. Endocrinol. Metab. 2009, 297, E271–E288. [Google Scholar] [CrossRef] [PubMed]
  34. Watt, M.J.; Holmes, A.G.; Pinnamaneni, S.K.; Garnham, A.P.; Steinberg, G.R.; Kemp, B.E.; Febbraio, M.A. Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am. J. Physiol. Endocrinol. Metab. 2006, 290, E500–E508. [Google Scholar] [CrossRef]
  35. Den Besten, G.; Gerding, A.; van Dijk, T.H.; Ciapaite, J.; Bleeker, A.; van Eunen, K.; Havinga, R.; Groen, A.K.; Reijngoud, D.J.; Bakker, B.M. Protection against the Metabolic Syndrome by Guar Gum-Derived Short-Chain Fatty Acids Depends on Peroxisome Proliferator-Activated Receptor γ and Glucagon-Like Peptide-1. PLoS ONE 2015, 10, e0136364. [Google Scholar] [CrossRef] [PubMed]
  36. Kang, J.H.; Lee, H.A.; Kim, H.J.; Han, J.S. Gelidium amansii extract ameliorates obesity by down-regulating adipogenic transcription factors in diet-induced obese mice. Nutr. Res. Pract. 2017, 11, 17–24. [Google Scholar] [CrossRef] [PubMed]
  37. Wi, S.G.; Kim, H.J.; Mahadevan, S.A.; Yang, D.J.; Bae, H.J. The potential value of the seaweed Ceylon moss (Gelidium amansii) as an alternative bioenergy resource. Bioresour. Technol. 2009, 100, 6658–6660. [Google Scholar] [CrossRef] [PubMed]
  38. Association of Official Analytical Chemists (AOAC). Official Methods of Analysis, 16th ed.; Association of Official Analytical Chemists (AOAC): Washington, DC, USA, 1996. [Google Scholar]
  39. Dubois, M.; Gilles, K.; Hamilton, J.K.; Rebers, P.A.; Smith, F. Colorimetric method for determination of sugars and related substances. Anal. Chem. 1956, 28, 350–356. [Google Scholar] [CrossRef]
  40. Cataldi, T.R.I.; Margiotta, G.; Zambonin, C.G. Determination of sugars and alditols in food samples by HPAEC with integrated pulsed amperometric detection using alkaline eluents containing barium or strontium ions. Food Chem. 1998, 62, 109–115. [Google Scholar] [CrossRef]
  41. Folch, J.; Lees, M.; Solane, G.M. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226, 497–509. [Google Scholar]
  42. Carlson, S.E.; Goldford, S. A sensitive enzymatic method of determination of free and esterified tissue cholesterol. Clin. Chim. Acta 1977, 79, 575–582. [Google Scholar] [CrossRef]
  43. Cheng, H.H.; Lai, M.H. Fermentation of resistant rice starch produces propionate reducing serum and hepatic cholesterol in rats. J. Nutr. 2000, 130, 1991–1995. [Google Scholar] [CrossRef] [PubMed]
  44. Berger, J.J.; Barnard, R.J. Effect of diet on fat cell size and hormone-sensitive lipase activity. J. Appl. Physiol. (1985) 1999, 87, 227–232. [Google Scholar] [CrossRef] [PubMed]
  45. Kusunoki, M.; Hara, T.; Tsutsumi, K.; Nakamura, T.; Miyata, T.; Sakakibara, F.; Sakamoto, S.; Ogawa, H.; Nakaya, Y.; Storlien, L.H. The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet. Diabetologia 2000, 43, 875–880. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Marinedrugs 17 00532 g001 550
Figure 1. Effects of GHE on body weight in hamsters fed different diets for 14 weeks during induction period (weeks 0–5) and experimental period (weeks 6–14). Data are presented as mean ± SD (n = 8). Con: Normal control group; HF: Obese hamsters fed a high-fat diet; GG: Obese hamsters fed 3% guar gum in the high-fat diet; GHE: Obese hamsters fed 3% Gelidium amansii hot-water extract in the high-fat diet; OL: Obese hamsters fed a high-fat diet with orlistat (200 mg/kg diet) in the diet. Values denoted by different letters differ significantly (p < 0.05) among one another.
Figure 1. Effects of GHE on body weight in hamsters fed different diets for 14 weeks during induction period (weeks 0–5) and experimental period (weeks 6–14). Data are presented as mean ± SD (n = 8). Con: Normal control group; HF: Obese hamsters fed a high-fat diet; GG: Obese hamsters fed 3% guar gum in the high-fat diet; GHE: Obese hamsters fed 3% Gelidium amansii hot-water extract in the high-fat diet; OL: Obese hamsters fed a high-fat diet with orlistat (200 mg/kg diet) in the diet. Values denoted by different letters differ significantly (p < 0.05) among one another.
Marinedrugs 17 00532 g001
Marinedrugs 17 00532 g002 550
Figure 2. Effects of GHE on triglyceride content per gram (A) and total (B) paraepididymal and perirenal fat pads in hamsters fed different experimental diets for 9 weeks. Data are presented as mean ± SD (n = 8). Con: Normal control group; HF: Obese hamsters fed a high-fat diet; GG: Obese hamsters fed 3% guar gum in the high-fat diet; GHE: Obese hamsters fed 3% Gelidium amansii hot-water extract in the high-fat diet; OL: Obese hamsters fed a high-fat diet with orlistat (200 mg/kg diet) in the diet. Values denoted by different letters differ significantly (p < 0.05) among one another.
Figure 2. Effects of GHE on triglyceride content per gram (A) and total (B) paraepididymal and perirenal fat pads in hamsters fed different experimental diets for 9 weeks. Data are presented as mean ± SD (n = 8). Con: Normal control group; HF: Obese hamsters fed a high-fat diet; GG: Obese hamsters fed 3% guar gum in the high-fat diet; GHE: Obese hamsters fed 3% Gelidium amansii hot-water extract in the high-fat diet; OL: Obese hamsters fed a high-fat diet with orlistat (200 mg/kg diet) in the diet. Values denoted by different letters differ significantly (p < 0.05) among one another.
Marinedrugs 17 00532 g002
Marinedrugs 17 00532 g003 550
Figure 3. Effects of GHE on lipolysis rate (A) and lipoprotein lipase activity (B) of paraepididymal and perirenal fat pads in hamsters fed different experimental diets for 9 weeks. Data are presented as mean ± SD (n = 8). Con: Normal control group; HF: Obese hamsters fed a high-fat diet; GG: Obese hamsters fed 3% guar gum in the high-fat diet; GHE: Obese hamsters fed 3% Gelidium amansii hot-water extract in the high-fat diet; OL: Obese hamsters fed a high-fat diet with orlistat (200 mg/kg diet) in the diet. Values denoted by different letters differ significantly (p < 0.05) among one another.
Figure 3. Effects of GHE on lipolysis rate (A) and lipoprotein lipase activity (B) of paraepididymal and perirenal fat pads in hamsters fed different experimental diets for 9 weeks. Data are presented as mean ± SD (n = 8). Con: Normal control group; HF: Obese hamsters fed a high-fat diet; GG: Obese hamsters fed 3% guar gum in the high-fat diet; GHE: Obese hamsters fed 3% Gelidium amansii hot-water extract in the high-fat diet; OL: Obese hamsters fed a high-fat diet with orlistat (200 mg/kg diet) in the diet. Values denoted by different letters differ significantly (p < 0.05) among one another.
Marinedrugs 17 00532 g003
Marinedrugs 17 00532 g004 550
Figure 4. Effects of GHE on the protein expressions of phosphorylated AMPK (A), PPARα (B), and UCP-2 (C) in the livers of hamsters fed different experimental diets for 9 weeks. Data are presented as mean ± SD for 4–5 Syrian hamsters. Con: Normal control group; HF: Obese hamsters fed a high-fat diet; GG: Obese hamsters fed 3% guar gum in the high-fat diet; GHE: Obese hamsters fed 3% Gelidium amansii hot-water extract in the high-fat diet; OL: Obese hamsters fed a high-fat diet with orlistat (200 mg/kg diet) in the diet. Values denoted by different letters differ significantly (p < 0.05) among one another.
Figure 4. Effects of GHE on the protein expressions of phosphorylated AMPK (A), PPARα (B), and UCP-2 (C) in the livers of hamsters fed different experimental diets for 9 weeks. Data are presented as mean ± SD for 4–5 Syrian hamsters. Con: Normal control group; HF: Obese hamsters fed a high-fat diet; GG: Obese hamsters fed 3% guar gum in the high-fat diet; GHE: Obese hamsters fed 3% Gelidium amansii hot-water extract in the high-fat diet; OL: Obese hamsters fed a high-fat diet with orlistat (200 mg/kg diet) in the diet. Values denoted by different letters differ significantly (p < 0.05) among one another.
Marinedrugs 17 00532 g004
Table
Table 1. Monosaccharide composition of the water-soluble indigestible polysaccharide from the Gelidium amansii hot-water extract (GHE).
Table 1. Monosaccharide composition of the water-soluble indigestible polysaccharide from the Gelidium amansii hot-water extract (GHE).
Molar Ratio of Monosaccharide Composition (100%)
FucRhaAraGalGlcManXylGalAGlcA
8.3 ± 0.10.5 ± <0.1nd86.0 ± 0.50.6 ± 0.11.5 ± <0.11.1 ± <0.1nd2.0 ± 0.1
Data are presented as mean ± SD (n = 3). Values were determined by high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD). Fuc: Fucose; Rha: Rhamnose; Ara: Arabinose; Gal: Galactose; Glc: Glucose; Man: Mannose; Xyl: Xylose; Gal A: Galacturonic acid; Glc A: Glucuronic acid; nd: Non-detected.
Table
Table 2. Effects of body weights, food intake and tissue weights in hamsters fed different diets for 9 weeks.
Table 2. Effects of body weights, food intake and tissue weights in hamsters fed different diets for 9 weeks.
ParametersConHFGGGHEOL
Initial body weight (g)106.4 ± 6.7 b118.4 ± 7.4 a115.9 ± 5.6 a116.9 ± 5.6 a116.2 ± 8.2 a
Final body weight (g)110.6 ± 8.7 d133.7 ± 9.4 a125.7 ± 3.0 b121.9 ± 3.9 bc115.5 ± 8.6 cd
Body weight gain (g)4.2 ± 7.9 bc15.3 ± 4.5 a9.8 ± 3.8 b5.0 ± 4.5 bc-0.7 ± 5.2 c
Food intake (g/days)8.3 ± 0.3 b8.1 ± 0.4 bc7.8 ± 0.4 c7.8 ± 0.4 c9.3 ± 0.3 a
Feed efficiency ratio (%)0.7 ± 1.4 cd2.7 ± 0.8 a1.8 ± 0.7 ab0.9 ± 0.8 bc−0.1 ± 0.8 d
Fasting body weight (g)108.3 ± 8.3 d130.6 ± 9.5 a123.5 ± 4.3 ab119.3 ± 3.8 bc113.2 ± 9.2 cd
Liver weight (g)3.2 ± 0.3 d6.1 ± 0.3 a5.1 ± 0.3 b5.0 ± 0.1 b3.6 ± 0.2 c
Relative liver weight (g/100 g BW)3.0 ± 0.2 d4.7 ± 0.2 a4.1 ± 0.1 b4.2 ± 0.1 b3.2 ± 0.2 c
Perirenal fat (g)1.0 ± 0.3 c2.0 ± 0.2 a1.8 ± 0.1 a1.5 ± 0.2 b1.2 ± 0.2 c
Paraepididymal fat (g)0.7 ± 0.2 d1.7 ± 0.2 a1.3 ± 0.1 b1.1 ± 0.2 c0.9 ± 0.2 c
White adipose tissue weight (g)1.7 ± 0.6 e3.6 ± 0.4 a3.1 ± 0.2 b2.6 ± 0.3 c2.1 ± 0.5 d
Relative white adipose tissue weight (g/100 g BW)1.5 ± 0.4 d2.8 ± 0.2 a2.5 ± 0.2 a2.1 ± 0.2 b1.8 ± 0.3 c
Data are presented as mean ± SD (n = 8). Con: Normal control group; HF: Obese hamsters fed a high-fat diet; GG: Obese hamsters fed 3% guar gum in the high-fat diet; GHE: Obese hamsters fed 3% Gelidium amansii hot-water extract in the high-fat diet; OL: Obese hamsters fed a high-fat diet with orlistat (200 mg/kg diet) in the diet. Values denoted by different letters differ significantly (p < 0.05) among one another. Food efficiency ratio (FER) = [weight gain (g)]/[total food intake (g)] × 100. Values denoted by different letters differ significantly (p < 0.05) among one another.
Table
Table 3. Effects of different diets on plasma biochemistry in hamsters for 9 weeks.
Table 3. Effects of different diets on plasma biochemistry in hamsters for 9 weeks.
ParametersConHFGGGHEOL
Glucose (mg/dL)148.8 ± 13.6 a153.3 ± 12.5 a144.2 ± 21.1 a144.9 ± 23.1 a161.0 ± 15.7 a
Triglyceride (mg/dL)58.4 ± 13.9 c173.7 ± 34.7 a139.3 ± 27.6 b128.1 ± 21.2 b119.8 ± 28.1 b
Total cholesterol (mg/dL)80.6 ± 13.4 d390.1 ± 76.9 a252.4 ± 31.7 b285.9 ± 42.0 b136.4 ± 22.5 c
Leptin (pg/mL)245.4 ± 81.3 d818.6 ± 241.9 a607.9 ± 232.0 b484.0 ± 155.5 bc352.5 ± 134.2 cd
TNFα (pg/mL)37.7 ± 1.4 d53.8 ± 1.2 a40.5 ± 1.8 b39.2 ± 2.1 bc37.3 ± 0.7 cd
IL-6 (pg/mL)10.5 ± 1.5 b21.5 ± 8.2 a11.8 ± 3.2 b10.2 ± 3.4 b8.8 ± 2.1 b
Data are presented as mean ± SD (n = 8). Con: Normal control group; HF: Obese hamsters fed a high-fat diet; GG: Obese hamsters fed 3% guar gum in the high-fat diet; GHE: Obese hamsters fed 3% Gelidium amansii hot-water extract in the high-fat diet; OL: Obese hamsters fed a high-fat diet with orlistat (200 mg/kg diet) in the diet. Values denoted by different letters differ significantly (p < 0.05) among one another.
Table
Table 4. Effects of different diets on liver and fecal lipid concentrations in Syrian hamsters for 9 weeks.
Table 4. Effects of different diets on liver and fecal lipid concentrations in Syrian hamsters for 9 weeks.
LipidsConHFGGGHEOL
Liver
Total cholesterol (mg/g Liver)5.9 ± 1.9 d71.2 ± 6.4 a42.8 ± 5.8 b40.4 ± 6.5 b17.0 ± 6.7 c
Total cholesterol (mg/Liver)19.1 ± 7.3 d434.1 ± 44.1 a218.3 ± 31.9 b201.2 ± 31.3 b61.0 ± 21.6 c
Triglyceride (mg/g Liver)2.9 ± 0.4 d9.5 ± 1.1 a7.8 ± 1.7 b6.1 ± 1.6 c7.3 ± 1.5 bc
Triglyceride (mg/Liver)9.2 ± 1.7 d57.6 ± 5.6 a39.4 ± 7.9 b30.6 ± 7.9 c26.6 ± 5.9 c
Feces
Total cholesterol (mg/g feces)3.7 ± 0.5 d4.7 ± 0.9 cd5.0 ± 1.3 c10.3 ± 1.1 a7.1 ± 1.5 b
Total cholesterol (mg/day)4.3 ± 0.6 b5.5 ± 1.3 b5.3 ± 1.7 b11.8 ± 1.6 a12.5 ± 3.5 a
Triglyceride (mg/g feces)3.2 ± 0.2 c3.5 ± 0.3 c4.7 ± 0.5 b4.7 ± 0.3 b106.4 ± 13.8 a
Triglyceride (mg/day)3.8 ± 0.4 c4.0 ± 0.5 c5.0 ± 0.7 b5.5 ± 0.7 b185.5 ± 29.4 a
Data are presented as mean ± SD (n = 8). Con: Normal control group; HF: Obese hamsters fed a high-fat diet; GG: Obese hamsters fed 3% guar gum in the high-fat diet; GHE: Obese hamsters fed 3% Gelidium amansii hot-water extract in the high-fat diet; OL: Obese hamster fed a high-fat diet with orlistat (200 mg/kg diet) in the diet. Values denoted by different letters differ significantly (p < 0.05) among one another.
Table
Table 5. Composition of experimental diets (%).
Table 5. Composition of experimental diets (%).
CompositionConHFGGGHEOL
Chow diet10086.986.986.986.9
Coconut oil-6666
Soybean oil-4444
Cholesterol-0.10.10.10.1
Cellulose-3--3
Gelidium amansii hot-water extract---3-
Guar gum--3 -
Total 100100100100100
Orlistat----200 mg/kg diet
Kcal (100 g) 345.6396.3395.9396.9396.3
Con: Hamsters fed a chow diet group; HF: Obese hamsters fed a high-fat diet group; GG: Obese hamsters fed 3% guar gum in the high-fat diet group; GHE: Obese hamsters fed 3% Gelidium amansii hot-water extract in the high-fat diet; OL: Obese hamsters fed a high-fat diet with orlistat (200 mg/kg diet).

Share and Cite

MDPI and ACS Style

Yang, T.-H.; Chiu, C.-Y.; Lu, T.-J.; Liu, S.-H.; Chiang, M.-T. The Anti-Obesity Effect of Polysaccharide-Rich Red Algae (Gelidium amansii) Hot-Water Extracts in High-Fat Diet-Induced Obese Hamsters. Mar. Drugs 2019, 17, 532. https://doi.org/10.3390/md17090532

AMA Style

Yang T-H, Chiu C-Y, Lu T-J, Liu S-H, Chiang M-T. The Anti-Obesity Effect of Polysaccharide-Rich Red Algae (Gelidium amansii) Hot-Water Extracts in High-Fat Diet-Induced Obese Hamsters. Marine Drugs. 2019; 17(9):532. https://doi.org/10.3390/md17090532

Chicago/Turabian Style

Yang, Tsung-Han, Chen-Yuan Chiu, Ting-Jang Lu, Shing-Hwa Liu, and Meng-Tsan Chiang. 2019. "The Anti-Obesity Effect of Polysaccharide-Rich Red Algae (Gelidium amansii) Hot-Water Extracts in High-Fat Diet-Induced Obese Hamsters" Marine Drugs 17, no. 9: 532. https://doi.org/10.3390/md17090532

APA Style

Yang, T. -H., Chiu, C. -Y., Lu, T. -J., Liu, S. -H., & Chiang, M. -T. (2019). The Anti-Obesity Effect of Polysaccharide-Rich Red Algae (Gelidium amansii) Hot-Water Extracts in High-Fat Diet-Induced Obese Hamsters. Marine Drugs, 17(9), 532. https://doi.org/10.3390/md17090532

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop